NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

Linda Liau is speaking at the 2nd Annual Glioblastoma Drug Development Summit on December 9th

Linda Liau
Chair of Neurosurgery
UCLA

Day One
Wednesday, December 09, 2020
10:00 am | Optimize the Role of Immunotherapy for Treatment of Glioblastoma

Synopsis
* Outline the historical and current understanding of the mechanisms of
* immune responses against glioblastoma
* Discuss the common challenges of designing and evaluating clinical
* trials of immunotherapy for glioblastoma
* Elucidate the considerations of timing, sequence, and tumor/patient
* heterogeneity in developing combination immunotherapy/vaccine trials
* for glioblastoma


Day Two
Thursday, December 10, 2020
11:00 am | PANEL DISCUSSION: Recognize the Financial Difficulty of Developing Glioblastoma Treatments and Moving Drugs to the Next Phase

* James Garner ?Chief Executive Officer & Managing Director, Kazia Therapeutics Limited
* Petra Hamerlik? Associate Research Director/Bioscience, AstraZeneca
* Ranjit S. Bindra? Associate Professor of Therapeutic Radiology, Yale School of Medicine
* Linda Liau? Chair of Neurosurgery, UCLA

Synopsis
* Explore the challenges of funding development
* How can drug developers inspire and attract companies to invest in their novel preclinical glioblastoma development and pipeline?
* How can the industry come together to overcome the paucity of funding?

https://glioblastoma-drugdevelopment.com/about/speakers/


Sorry if this is a repeat, I haven’t been keeping up.